Peter Bock

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock et al. · The Lancet · 2022 · 540 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)

Richard Hayes, Deborah Donnell, Sian Floyd et al. · New England Journal of Medicine · 2019 · 351 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +14

HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial

Richard Hayes, Helen Ayles, Nulda Beyers et al. · Trials · 2014 · 227 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Long-term Survivorship of Rotator Cuff Repairs Using Ultrasound and Magnetic Resonance Imaging Analysis

Rainer Kluger, Peter Bock, Martina Mittlböck et al. · The American Journal of Sports Medicine · 2011 · 212 citations

Medicine, Orthopedic Surgery, Surgery +17

Better Antiretroviral Therapy Outcomes at Primary Healthcare Facilities: An Evaluation of Three Tiers of ART Services in Four South African Provinces

Geoffrey Fatti, Ashraf Grimwood, Peter Bock · PLoS ONE · 2010 · 130 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +16